All Cardiovascular articles
-
AnimationChanges to the NICE atrial fibrillation (AF) guideline and anticoagulation treatment options—what do they mean to you?
This promotional animation has been commissioned by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼ (rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-2154 December 2021 -
NICE guideline
NICE heart valve disease guideline
Covering investigation and management of heart valve disease in adults
-
News
Heart failure could be diagnosed earlier in primary care
New research suggests that three-quarters of patients with heart failure could be identified earlier with increased natriuretic peptide testing in primary care
-
News
NICE publishes updated guidance on the management of acute heart failure
The guideline includes recommendations on diagnosis, assessment and monitoring, initial pharmacological and nonpharmacological treatment, management after stabilisation, and the use of mechanical devices
-
Guidance card
Empagliflozin (Jardiance®) 10mg film-coated tablets SMC2396
The production of this Guidelines summary card has been commissioned by the Boehringer Ingelheim and Lilly Alliance.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain and Northern Ireland.
PC-GB-105816 October 2021 -
News
NICE publishes guideline on the management of heart valve disease
The new guidance outlines how adults with heart valve disease should be investigated and managed
-
News
Publicly available defibrillators less common in deprived areas
New research shows that publicly accessible AEDs are not located in the areas that need them most
-
News
PSNC offers new resources on Hypertension Case-Finding Service
Community pharmacy can offer the advanced service to identify undiagnosed cases of cardiovascular disease and support general practice in the prevention and management of cardiovascular conditions
-
NICE guideline
NICE CVD guideline
A concise summary of NICE's evidence-based clinical guideline on lipid modification for the prevention of cardiovascular disease
-
News
Serum vitamin D associated with mortality in patients with existing CVD
Serum vitamin D may be linked to mortality in patients with existing CVD, researchers from Tongji Medical College have found
-
News
NICE: inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia
NICE has issued new guidance that recommends inclisiran as an option for treating primary hypercholesterolaemia or mixed dyslipidaemia
-
News
EMA confirms risk of new blood disorder with Janssen COVID-19 vaccine
The Agency’s Pharmacovigilance Risk Assessment Committee recommends raising awareness of a possible link between the vaccine and VTE
-
Video
Updates in best practice management of venous thromboembolism
These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100782 | Date of preparation: September 2021 -
News
SIGN releases draft guidance on venous thromboembolism in COVID-19
The draft rapid guideline is open for consultation until 3 October
-
Independent professional body guideline
ABCD position on cardiovascular impact of glucose-lowering drugs
Key recommendations from the ABCD position statement on new glucose-lowering drugs concerning their cardiovascular impact on people with diabetes
-
News
NHS England to routinely offer novel cholesterol-lowering jab
The twice-yearly inclisiran injection, which will be available through GP surgeries across England, could save 30,000 lives over the next 10 years
-
Video
Modern management of stroke prevention in non-valvular atrial fibrillation
These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100689 | Date of preparation: August 2021 -
News
Renal decline slower with rivaroxaban than warfarin in patients with atrial fibrillation
Patients with atrial fibrillation report fewer adverse renal outcomes and a slower decline in renal function on rivaroxaban compared with warfarin
-
News
Blood pressure checks to be rolled out in community pharmacies across England
From October, every NHS pharmacy in England will be able to offer blood pressure checks to people aged 40 and over
-
NICE guideline
COVID-19 rapid guideline on VITT
This Guidelines summary covers vaccine-induced immune thrombocytopenia and thrombosis, a syndrome that has been reported in rare cases after COVID-19 vaccination
